Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Report
|
Pfizer Therapeutic Research, Formerly Known as Warner Lambert Company, Pfizer Worldwide Research & Development Division, Antibacterials Research Unit, Pharmacokinetics, Dynamics and Metabolism Department, Antibacterial Chemistry Department, Analytical Chemistry and Material Management Department Groton, CT; Amended Certification Regarding Eligibility To Apply for Worker Adjustment AssistanceThe Federal Register / FIND, 2012, Vol.77 (113), p.35060Washington: Federal Information & News Dispatch, LLCTexto completo disponível |
|
2 |
Material Type: Report
|
Green Wave Analytical Decision and OrderThe Federal Register / FIND, 2023, Vol.88 (177), p.63124Washington: Federal Information & News Dispatch, LLCTexto completo disponível |
|
3 |
Material Type: Report
|
Changes to Accreditation of Non-Federal Analytical Testing LaboratoriesThe Federal Register / FIND, 2020, Vol.85 (240), p.80668Washington: Federal Information & News Dispatch, LLCTexto completo disponível |
|
4 |
Material Type: Report
|
Schedules of Controlled Substances: Placement of Oliceridine in Schedule IIThe Federal Register / FIND, 2021, Vol.86 (110), p.30772Washington: Federal Information & News Dispatch, LLCTexto completo disponível |
|
5 |
Material Type: Report
|
Schedules of Controlled Substances: Placement of Remimazolam in Schedule IVThe Federal Register / FIND, 2021, Vol.86 (104), p.29506Washington: Federal Information & News Dispatch, LLCTexto completo disponível |
|
6 |
Material Type: Report
|
Schedules of Controlled Substances: Placement of Ganaxolone in Schedule VThe Federal Register / FIND, 2022, Vol.87 (216), p.67548Washington: Federal Information & News Dispatch, LLCTexto completo disponível |
|
7 |
Material Type: Report
|
Schedules of Controlled Substances: Placement of Daridorexant in Schedule IVThe Federal Register / FIND, 2022, Vol.87 (189), p.59296Washington: Federal Information & News Dispatch, LLCTexto completo disponível |
|
8 |
Material Type: Report
|
Schedules of Controlled Substances: Placement of N-Ethylhexedrone, alpha-Pyrrolidinohexanophenone, 4-Methyl-alpha-ethylaminopentiophenone, 4'-Methyl-alpha-pyrrolidinohexiophenone, alpha-Pyrrolidinoheptaphenone, and 4'-Chloro-alpha-pyrrolidinovalerophenone in Schedule IThe Federal Register / FIND, 2022, Vol.87 (105), p.32996Washington: Federal Information & News Dispatch, LLCTexto completo disponível |
|
9 |
Material Type: Report
|
Schedules of Controlled Substances: Placement of 5F-EDMB-PINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA, and FUB-144 in Schedule IThe Federal Register / FIND, 2022, Vol.87 (67), p.20318Washington: Federal Information & News Dispatch, LLCTexto completo disponível |
|
10 |
Material Type: Report
|
Schedules of Controlled Substances: Placement of N-Ethylhexedrone, alpha-Pyrrolidinohexanophenone, 4-Methyl-alpha-ethylaminopentiophenone, 4'-Methyl-alpha-pyrrolidinohexiophenone, alpha-Pyrrolidinoheptaphenone, and 4'-Chloro-alpha-pyrrolidinovalerophenone in Schedule IThe Federal Register / FIND, 2021, Vol.86 (134), p.37719Washington: Federal Information & News Dispatch, LLCTexto completo disponível |